{
     "PMID": "20962363",
     "OWN": "NLM",
     "STAT": "MEDLINE",
     "DCOM": "20110324",
     "LR": "20131121",
     "IS": "1419-8711 (Print) 1419-8711 (Linking)",
     "VI": "12",
     "IP": "3",
     "DP": "2010 Sep",
     "TI": "[Application of lamotrigine in bipolar disorder--3T MR spectroscopy follow up (part 1)].",
     "PG": "433-41",
     "AB": "MR spectroscopy (MRS) is a widely used and useful additional tool in the diagnostic process of several neuropsychiatric disorders. Despite several MRS studies in bipolar spectrum research, establishing a clean image about special metabolite alterations in the disorder still needs further investigation. The first part of this case study presents a bipolar II patient and her first 3T MR spectroscopy in drug-naive conditions, comparing to a healthy subject. Having finished the first MRS investigation, we applied lamotrigine medication. The ongoing second part of the study will show the data of the second MRS scan, after 5 month of lamotrigine therapy.",
     "FAU": [
          "Sumegi, Andras",
          "Halasz, Szabolcs",
          "Kliment, Edit"
     ],
     "AU": [
          "Sumegi A",
          "Halasz S",
          "Kliment E"
     ],
     "AD": "Vas Megyei Markusovszky Korhaz Nonprofit Zrt., Pszichiatriai Centrum, Hungary.",
     "LA": [
          "hun"
     ],
     "PT": [
          "English Abstract",
          "Journal Article"
     ],
     "TT": "Lamotrigin alkalmazasa bipolaris zavarban - 3T MR spektroszkopias utankovetessel (1. resz).",
     "PL": "Hungary",
     "TA": "Neuropsychopharmacol Hung",
     "JT": "Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakologiai Egyesulet lapja = official journal of the Hungarian Association of Psychopharmacology",
     "JID": "100961631",
     "RN": [
          "0 (Antimanic Agents)",
          "0 (Excitatory Amino Acid Antagonists)",
          "0 (Triazines)",
          "30KYC7MIAI (Aspartic Acid)",
          "997-55-7 (N-acetylaspartate)",
          "MU72812GK0 (Creatine)",
          "N91BDP6H0X (Choline)",
          "U3H27498KS (lamotrigine)"
     ],
     "SB": "IM",
     "MH": [
          "Antimanic Agents/*therapeutic use",
          "Aspartic Acid/analogs & derivatives/metabolism",
          "Bipolar Disorder/*drug therapy/metabolism/*pathology",
          "Choline/metabolism",
          "Creatine/metabolism",
          "Excitatory Amino Acid Antagonists/therapeutic use",
          "Female",
          "Hippocampus/*metabolism/*pathology",
          "Humans",
          "*Magnetic Resonance Spectroscopy",
          "Treatment Outcome",
          "Triazines/*therapeutic use",
          "Young Adult"
     ],
     "EDAT": "2010/10/22 06:00",
     "MHDA": "2011/03/25 06:00",
     "CRDT": [
          "2010/10/22 06:00"
     ],
     "PHST": [
          "2010/10/22 06:00 [entrez]",
          "2010/10/22 06:00 [pubmed]",
          "2011/03/25 06:00 [medline]"
     ],
     "PST": "ppublish",
     "SO": "Neuropsychopharmacol Hung. 2010 Sep;12(3):433-41.",
     "term": "hippocampus"
}